Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
121 studies found for:    Open Studies | "Bile Duct Diseases"
Show Display Options
Rank Status Study
21 Recruiting Fecal Microbiota Transplantation for the Treatment of Primary Sclerosing Cholangitis.
Condition: Sclerosing Cholangitis
Intervention: Biological: Fecal Microbiota Transplantation
22 Recruiting Standard Lipid Therapy vs IVFE Minimization for Prevention of PNALD
Condition: Cholestasis
Intervention: Drug: Intralipid 20% I.V. Fat Emulsion
23 Recruiting Omegaven® as Parenteral Nutrition
Condition: Cholestasis
Intervention: Drug: Omegaven
24 Recruiting A Trial of BTT1023 in Patients With Primary Sclerosing Cholangitis
Condition: Primary Sclerosing Cholangitis
Intervention: Drug: BTT1023
25 Recruiting Mitomycin C Therapy for Patients With Primary Sclerosing Cholangitis
Condition: Primary Sclerosing Cholangitis
Interventions: Drug: Mitomycin C;   Drug: Normal saline
26 Recruiting Prospective Randomized Clinical Trial of Intravenous Lipids and Cholestasis
Condition: Parenteral Nutrition Associated Cholestasis
Intervention: Drug: intravenous lipid
27 Recruiting Compassionate Use of Omegaven to Reverse Parenteral Nutrition Induced Cholestasis
Condition: Cholestasis
Intervention: Drug: Omegaven
28 Recruiting Genomics of Primary Sclerosing Cholangitis (PSC)
Condition: Primary Sclerosing Cholangitis (PSC)
Intervention: Genetic: Genetic Analysis
29 Recruiting Safety and Efficacy Study of Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis
Condition: Primary Sclerosing Cholangitis
Intervention: Drug: ursodeoxycholic acid (UDCA)
30 Recruiting A Safety and Efficacy Study to Determine if Giving Intravenous Fish Oil Helps Children With Liver Disease
Condition: Cholestasis
Intervention: Drug: Omegaven
31 Recruiting Compassionate Use of an Intravenous Fish Oil Emulsion in the Treatment of Liver Injury in Infants
Conditions: Cholestasis;   Cholestasis of Parenteral Nutrition
Intervention: Drug: Omegaven
32 Recruiting Compassionate Use of Omegaven IV Fat Emulsion
Conditions: Cholestasis;   Liver Disease
Intervention: Drug: Omegaven IV
33 Recruiting Use of Omegaven Fish Oil Emulsion for Parenteral Nutrition Associated Liver Disease in Infants and Children
Condition: Cholestasis
Intervention: Drug: Omega-3 fish oil lipid emulsion
34 Recruiting Serum Autotaxin Levels in Cholestasis of Pregnancy
Condition: Intrahepatic Cholestasis of Pregnancy
Intervention:
35 Available SMOF Lipid for Children With Parenteral Nutrition Induced Liver Injury
Conditions: Cholestasis;   Growth Failure
Intervention: Drug: SMOFlipid
36 Recruiting Registry Trial to Determine pCLE Image Interpretation Criteria and Preliminary Accuracy for PSC Biliary Strictures
Condition: Primary Sclerosing Cholangitis
Intervention: Device: probe based confocal laser endomicroscopy
37 Not yet recruiting Comparison of Diagnostic Accuracy Before or After Stricture Dilation in Biliary Stricture
Condition: Biliary Strictures
Intervention: Procedure: Multimodal tissue-sampling methods before and after stricture dilation
38 Recruiting Trial Comparing Kaffes Stent With Plastic Prosthesis in the Treatment of Anastomotic Biliary Strictures Post Orthotopic Liver Transplantation
Condition: Biliary Strictures Post Liver Transplantation.
Interventions: Procedure: Plastic stenting;   Procedure: Kaffes stenting
39 Recruiting Haemodynamic Stability of Ketamine/Propofol Admixture "Ketofol" in Patient Undergoing Endoscopic Retrograde Cholangio Pancreatography
Conditions: Pancreatitis;   Cholangitis
Interventions: Drug: Ketamine / Propofol Admixture;   Drug: Propofol
40 Recruiting EUS Guided ERCP in Bile Duct Stone Removal
Condition: Choledocholithiasis
Interventions: Procedure: ERCP without the use of fluoroscopy;   Procedure: ERCP with the use of fluoroscopy

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.